(CercleFinance.com) – Barclays reaffirms its ‘overweight’ advice on ASML with a price target raised from 800 to 900 euros, judging that ‘concerns about the cycle and postponements of revenue recognition have overshadowed what has been shown otherwise a very solid release from ASML’.
Pointing to ‘a limited impact of the fire for 2022 and above all a clear increase in the 2023-25 figures with ASML already planning to raise its supply chain even further’, the broker is now 11%/15% above the 2025 consensus sales/profits.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
